Skip to content

The intervention of repetitive transcranial magnetic stimulation for methcathinone addicts

Cortical function assessment and intervention study of repetitive transcranial magnetic stimulation for drug addiction

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024976
Enrollment
Unknown
Registered
2019-08-05
Start date
2019-08-09
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methcathinone Addiction

Interventions

10 Hz L-DLPFC group:10 Hz L-DLPFC

Sponsors

China University of Political Science and Law
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 60 years; (2) At the third grade or above in primary school, able to read and understand basic sentences; (3) The duration of drug abuse is more than one year, the frequency of use is more than once a week, and the monthly use is greater than 1 gram; (4) Willing to participate in the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) There are contraindications to transcranial magnetic (TMS) treatment, such as head trauma, history of epilepsy, and metal implants in the body; (2) Other mental illnesses other than substance-related and addictive disorders (e.g., depression, bipolar disorder, schizophrenia); (3) A serious physical illness or a major organ disease; (4) Intelligence impairment (IQ<90).

Design outcomes

Primary

MeasureTime frame
EEG signal;Craving;

Secondary

MeasureTime frame
Neuropsychological (e.g., depression, anxiety, craving, sleep, impulsivity, suicide attitude, obsessive symptom);Cognitive functions (e.g., inhibit control, working memory, decision making);

Countries

China

Contacts

Public ContactBo Yang

School of Socialogy, China University of Political Science and Law

zsdybo@sina.com+86 13501360249

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026